We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Cold Plasma Jet Welds Shut Surgical Incisions

By HospiMedica International staff writers
Posted on 01 Jul 2013
A prototype cold plasma biowelding device for external surgical incisions reduces complications, diminishes scarring, and trims procedure time and cost.

The BioWeld1 system is comprised of a helium tank, a main unit the size of a shoebox, a hand-piece, and a variety of disposable tips to deliver the cold plasma jet, enhancing coagulation and generating an instant closure concomitant to wound disinfection. More...
The device possesses two different modes of operation; the first uses a cold plasma jet to apply a trademarked biological film called Chitoplast to weld the tissue together. Other applications in development do not require Chitoplast, and rely solely on the tissue effects of the plasma jet.

Among the advantages of the system are improved patient satisfaction, less scarring, reduced hospital-acquired infections (HAIs),reduced pain, no need to remove sutures, reduced length of stay, improved clinical outcomes, reduced complications, improved incision healing and sealing, and reduced hospital costs and procedure length. The system requires a relatively short learning curve and improves operating room (OR) utilization. The BioWeld1 system is under development by IonMed (Yokneam Illit, Israel).

The company has so far conducted three clinical trials, which have focused on closure of Caesarean section incisions. The result show the BioWeld1 system to be excellent for sealing the incision and promoting healing and tissue disinfection, and also holds the potential for reducing hospitalization and operating room time. Other areas under consideration include external closure of incisions in plastic surgery, the treatment of chronic wounds, and internal applications in abdominal, thoracic, and colorectal surgery.

“No one has done this before and more than that, the platform of cold plasma is a technology that is not available in medicine yet. We will probably be the first,” said Ronen Lam, co-founder and vice president for business development at IonMed, in an interview with ISRAEL21c. “Tissue reconnection has been done for thousands of years with sutures, and in recent years with staples and glues. It is time for something new in this traditional market, and that’s why we decided to start here.”

Plasma is one of the four fundamental states of matter, the others being solid, liquid, and gas. Heating a gas or using a strong electromagnetic field applied with a laser ionizes its molecules or atoms—reducing or increasing the number of electrons in them—thus turning it into plasma, which contains charged particles: positive ions and negative electrons or ions, accompanied by dissociation of molecular bonds. Plasma has so far enjoyed a limited role in surgery due to the high temperatures it creates and resulting harmful effects on body tissue.

Related Links:

IonMed



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.